Home > Boards > US OTC > Biotechs >

Collexis (CLXS)

Add CLXS Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/2/2015 1:25:54 PM - Followers: 12 - Board type: Free - Posts Today: 0

Board of Director Information - Board of Directors updated with Nevada Secretary of State

Last filing

Action Type: Annual List
Document Number: 20100957302-59 # of Pages: 2
File Date: 12/28/2010 Effective Date:
(No notes for this action)

Board of Directors:

Frank C. Carlucci has served as Vice-Chairman of the Board since June 2007. Mr. Carlucci currently serves as Chairman Emeritus for The
Carlyle Group, in Washington D.C. From November 1987 to January 1989, Mr. Carlucci served as U.S. Secretary of Defense, following his
service as Assistant to the President for National Security Affairs under President Ronald Reagan in 1987. Prior to serving in these positions, he
was Chairman and CEO of Sears World Trade, a business he joined in 1983. Mr. Carlucci has had a career in government service, including
serving as Deputy Secretary of Defense from 1980 to 1982, Deputy Director of Central Intelligence from 1978 to 1980, U.S. Ambassador to
Portugal from 1975 to 1978, Under Secretary of Health Education and Welfare from 1973 to 1975, Deputy Director of OMB from 1970 to 1972,
and Director of the Office of Economic Opportunity in 1969. Mr. Carlucci was a Foreign Service Officer from 1956 to 1980, and served as an
officer in the U.S. Navy from 1952 to 1954.

Mark Germain
Mr. Germain was appointed Co-Chairman of the Board of Directors on May 17, 2007. For more than the past five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries. He has been involved as a founder, director, Chairman of the Board of, and/or investor in over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions. He graduated New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law before leaving for the private sector in 1986. Since then, and until he entered the biotech field in 1991, he served in senior executive capacities, including as president of a public company sold in 1991. In addition to being Co-Chairman of the Company, Mr. Germain is a director of the following publicly traded companies: Wellford Real Properties, Inc., Stem Cell Innovations, Inc., and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companies in the biotechnology field





William D. Kirkland, Bill has been Chief Executive Officer and President of Collexis Holdings Inc. since February 2007. Mr. Kirkland served as Chief Financial Officer and Chief Accounting Officer of Collexis Holdings Inc. until April 7, 2008. He served as Chief Executive Officer and President of Collexis, Inc., a subsidiary of Collexis B.V., from February 2006 to February 2007. From August 2001 to February 2006, Mr. Kirkland served as Business Unit Executive, (Americas) Life Sciences Business Consulting Services for IBM. Mr. Kirkland has a 20-year career of managerial and executive assignments throughout Pfizer and IBM. During this period, Mr. Kirkland ran multiple sales, business unit, operational, and product marketing teams. In his last assignment, he ran the Business Consulting Services Sales division of IBM's Life Sciences Business in the Americas. He served as Vice President of Life Sciences Division, of Nutec Sciences, Inc., from October 2000 to August 2001. From 1991 to October 2000, Mr. Kirkland served as Director of Training and Development - Pfizer Limited, United Kingdom. He serves on the boards of several industry organizations and groups throughout the United States. He serves as a Director for SEBIO and Georgia BioMed Partners. He has been Director of Collexis Holdings Inc. since January 2006. Mr. Kirkland holds a Bachelor of Science in Criminal Justice from the University of South Carolina.

Stephen Leicht - formerly Collexis Integration Director - Collexis Acquisition at Elsevier, Executive Vice President and Chief Operating Officer at Collexis Holdings Inc., Executive Vice President, Sales at Collexis, Director of Operations, Americas at Collexis

After completing his Business Degree at Bucknell University in Pennsylvania, Stephen founded, ran, and sold International Telecommunications Distributors, acting as Chairman and CEO until late 2001. After the sale, he completed his MBA at Pennsylvania State University as the President of his class. Steve spent the 5 following years in increasing roles of responsibility within IBM's Sales and Distribution organization before joining Collexis in early 2006. In his last assignment, Stephen ran a $130M Carolinas Region for IBM Sales & Distribution. In his current assignment, Steve leads the management of the company’s three industry business units and the overall execution of Collexis Worldwide operations. He serves on boards and advisory committees for several companies and industry groups.


Fundraising, Mergers & Acquisitions, Public Markets Financing, Sales Hiring, Sales Training, Sales Integration, PR, IR, Sarbanes Oxley Process & Audit for S&D, branding and identity managements, competitive analysis, business plan writing and execution, venture capital and private equity, matrix management, virtual teams and organizations, OEM sales, VAR initiation and management, Strategic Alliances, Executive Recruiting, Board Recruiting, etc.

John D. Macomber (born January 13, 1928) in Rochester, New York is the principal of JDM Investment Group and was the President of the Export-Import Bank of the United States from 1989 to 1992. He was a Senior Partner at McKinsey & Co. until 1973 and Chairman and CEO of Celanese Corporation until 1986. Mr. Macomber is also Chairman of the Council for Excellence in Government, Rand McNally and Company, and Vice Chairman of the Atlantic Council. He has retired from serving on the Board of Directors of Lehman Brothers, Bristol-Myers Squibb Company, The Brown Group, Inc., Chase Manhattan Bank, RJR Nabisco, Pilkington Ltd., and Xerox Corporation.

Macomber graduated from Phillips Academy, Yale University in 1950, and Harvard Business School in 1952

John Regazzi  Professor and Past Dean, College of Information and Computer Science, Director at Collexis, Chair, Advisory Board at NTIS, Professor and Director, Information Innovation Lab at Long Island University

Past - Dean at College of Information & Computer Science at Long Island University, CEO at Elsevier Inc, , CEO and Managing Director at Elsevier (Division of Reed Elsevier)

  • Rutgers, The State University of New Jersey-New Brunswick
  • Columbia University in the City of New York

Andrew A. Sorensen -Ohio State University has tapped a two-time university president as its new chief fund-raiser.

Andrew A. Sorensen, a former president of the University of South Carolina and the University of Alabama, will lead Ohio State's development efforts, including its $2.5 billion comprehensive campaign. He also will serve as president of the Ohio State University Foundation.

Pending board approval, Sorensen, 72, will take over as senior vice president for University Development on Oct. 5. He replaces Peter Weiler, who announced yesterday he was leaving OSU for a position at the University of New Hampshire to be closer to family on the East Coast. Sorensen's salary is $400,000.

"Dr. Sorensen is one of the country's most senior leaders in higher education, and we are remarkably fortunate to have attracted him to lead the university's comprehensive development efforts," President E. Gordon Gee said in a statement this morning.

Quite an impressive Board of Directors for our little gem!


Investor relations
Sybella Stanley
Reed Elsevier Group plc
1-3 Strand
Telephone: +44 (0)20 7166 5634

James Statham
Reed Elsevier Group plc
1-3 Strand
Telephone: +44 (0)20 7166 5634

For US investor inquiries please contact:

Ken Fogarty
Reed Elsevier Inc.
2 Newton Place
Suite 350, 3rd Floor
Newton, MA 02458-1637, USA
Telephone: +1 617 630 2104


Press Release Source: Collexis Holdings Inc.

Collexis Named KMWorld Trend-Setting Product of 2008
Thursday September 4, 8:30 am ET
Semantic Search and Knowledge Discovery Software Company Recognized for Second Consecutive Year for Its Innovative Technology

COLUMBIA, S.C.--(BUSINESS WIRE)--Collexis Holdings Inc. (OTCBB: CLXS - News), a leading developer of semantic search and knowledge discovery software, announced today that it has been named one of KMWorld magazine’s Trend-Setting Products of 2008. This marks the second consecutive year Collexis has been recognized for its groundbreaking and innovative technology. This is the sixth year of the KMWorld selection process.

“This year’s edition has been compiled through briefings with vendors themselves, along with conversations with analysts, users and system integrators,” said Hugh McKellar, KMWorld editor-in-chief. “Our mission selecting this year’s products has been deceptively simple: select those that deliver robust customer value.”

Collexis technology is based on the ability to identify and map ideas from data using vocabularies, like a thesaurus. The process is called Collexis Fingerprinting. It allows for expert profiling systems and a broad range of knowledge discovery applications and visualizations. Collexis also empowers the user to view their research results in a more productive manner and provides new insights or fields of study, which would never be revealed using conventional search or knowledge management approaches.

“We are honored that KMWorld has selected Collexis’ technology as a ‘Trend-Setting Product’ for the second consecutive year,” said Chief Executive Officer Bill Kirkland. “Since our last selection, in 2007, the market has validated what KMWorld saw first – that Collexis is a leader in Knowledge Discovery. Our new engagements with Johns Hopkins, Mayo Clinic, the National Institutes of Health and other leading life science institutions, have been complimented with similar growth in defense, intelligence and legal markets. We greatly appreciate the recognition of such a hallmark institution in Information Management.”

About KMWorld

KMWorld (www.kmworld.com) is the leading information provider serving the Knowledge Management systems market and covers the latest in Content, Document and Knowledge Management, informing more than 50,000 subscribers about the components and processes - and subsequent success stories - that together offer solutions for improving business performance. KMWorld is a publishing unit of Information Today, Inc. (www.infotoday.com)

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

Forward-Looking Statements

Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These risks and uncertainties are in addition to other factors detailed from time to time in the company’s filings with the SEC, including the section entitled “Risk Factors” in its transition report on Form 10-KSB for the period ended June 30, 2007, as amended. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

Chernoff Newman
Stephanie Jones, 803-233-2432
Collexis Holdings, Inc.
Darrell W. Gunter, EVP/CMO, 803-727-1113
Mobile: 973-454-3475

Source: Collexis Holdings Inc.

Email Story
Set News Alert
Print Story


Share price
Sunday, 09 January 2011, 02:43 PM (approx 20 mins delay)
  Latest Change  
REL Reed Elsevier PLC London(Pence) 535.66 4.66 View Chart
REN Reed Elsevier NV Amsterdam (EUR) 9.38 0.03 View Chart
RUK Reed Elsevier PLC New York (USD) 32.93 0.06 View Chart
ENL Reed Elsevier NV New York (USD) 24.20 -0.15 View Chart
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#307   bye bye Collexis! decouverte d Elbe 04/02/15 01:25:54 PM
#306   CLXS SEC Suspension: Renee 03/02/15 09:42:05 AM
#305   they'll run this every year or two, just decouverte d Elbe 12/17/14 04:53:35 AM
#304   ~ $CLXS ~ Daily Par Sar Buy Signal Penny Roger$ 07/11/13 07:43:20 PM
#303   Any clue what's going on here? I rookiecrd1 07/11/13 04:49:49 PM
#302   CLXS .005/.015 SuperC 07/11/13 03:25:45 PM
#301   CLXS .005/.0051 7.5mil bid .005 look out!! SuperC 07/11/13 03:24:40 PM
#300   what do you think is going on here Montana Wildhack 03/08/13 11:06:38 AM
#299   1,431,600 SHARES TODAY .... ByMorStock 03/07/13 04:30:40 PM
#298   still here ..nothing has changed. in this for decouverte d Elbe 06/13/11 05:23:31 PM
#296   This thing just keeps going down. And now stoper1 06/03/11 11:56:59 AM
#295   this is my nest egg..will add forever til decouverte d Elbe 05/25/11 12:36:15 PM
#294   added nice today..hope we hear something soon decouverte d Elbe 05/25/11 10:25:19 AM
#293   We closed up a bit today. ByMorStock 05/23/11 04:11:34 PM
#292   Thanks..this is our rainy day stock it seems decouverte d Elbe 05/22/11 09:18:47 PM
#291   Good for you, lars! Snook 05/22/11 07:48:49 PM
#290   What exactly will this shell turn out to be? ByMorStock 05/22/11 01:17:20 PM
#289   Nice....one day or in our "moment" it will lockednready 05/21/11 08:02:38 AM
#288   yay! i got 100,000 today at ask. And decouverte d Elbe 05/20/11 04:24:21 PM
#287   .005 a great pps and finally we have lockednready 05/18/11 12:55:47 PM
#286   Darn! someone got a sweet deal today! decouverte d Elbe 05/11/11 03:19:46 PM
#285   Sure would be nice to get some information ByMorStock 05/08/11 07:31:46 PM
#284   Anything under .03 cents is a steal...just waiting lockednready 05/08/11 07:13:58 PM
#283   No, I got out a few months ago. DirtyDawg 05/08/11 07:03:08 PM
#282   Scotch, are you still holding shares here? Snook 05/08/11 05:37:32 PM
#281   dang, they passed me up again! but that's decouverte d Elbe 05/06/11 01:40:51 PM
#280   We have all tried but the gentlemen of Snook 05/05/11 03:43:00 PM
#279   "the fog creeps in on little cat's feet" decouverte d Elbe 05/04/11 09:28:57 PM
#278   Is that significant? Not sure I follow. Doesnt stoper1 05/04/11 08:11:28 PM
#277   there's an open order in for 70,000 shares decouverte d Elbe 05/04/11 01:04:29 PM
#276   I hope not too soon from my own decouverte d Elbe 05/01/11 08:49:10 PM
#275   Who knows maybe we will hear something soon. lockednready 05/01/11 03:14:03 PM
#274   I can feel a buzz happening here..something's going decouverte d Elbe 04/14/11 09:22:50 AM
#273   they gave me 5000 yesterday! hard to get decouverte d Elbe 04/01/11 05:35:14 PM
#272   I haven't been posting because there isn't anything Montana Wildhack 03/31/11 10:30:21 PM
#271   I've been accumulating the last few weeks and lockednready 03/30/11 05:04:22 PM
#270   Hopefully we will see some developments here during Snook 03/29/11 09:59:26 AM
#269   So would I, ByMor, so would I. ;-) Snook 03/18/11 03:52:04 PM
#268   I want more .006s ByMorStock 03/16/11 05:54:05 PM
#267   MMs swapping shares..anyone getting a few? looks like decouverte d Elbe 03/16/11 03:32:47 PM
#266   wow..someone landed a few .006s, lucky person!..this stock decouverte d Elbe 03/16/11 12:11:07 PM
#265   Like I said , the MMs took all decouverte d Elbe 03/09/11 10:48:06 PM
#264   Lars, I am anxious for them to take Snook 03/09/11 07:22:32 PM
#263   MMs are grabbing shares now, and stealing from decouverte d Elbe 03/09/11 12:12:57 AM
#262   My suspension from ihub, Lars. :-) Snook 03/04/11 10:34:20 AM
#261   what suspension are you referencing? on a different stock? decouverte d Elbe 03/04/11 10:32:58 AM
#260   Congrats on being Scotttrade Free! I was Snook 03/04/11 10:28:03 AM
#259   upped the bid to .0053, and sat there decouverte d Elbe 03/02/11 12:18:53 PM
#258   A $1.15 CLXS trade yesterday? Am I seeing stoper1 03/01/11 11:35:38 AM
#257   thanks for the informative DD. This is definitely decouverte d Elbe 02/28/11 09:59:18 AM